Macular Disease Foundation Australia aims to work collaboratively with health professionals to improve health literacy around macular disease.
We share a common interest with you, in encouraging patients to take early action to save sight.
Our objective is to build a ‘go to’ macular disease hub for health practitioners who have an interest in the macula and are keen to learn about the latest developments in macular research, resources and services available to support patients.
We encourage health professionals to refer your macular disease patients to MDFA at the earliest opportunity for expert, independent and free advice, and support.
By referring any patient at risk of or living with macular disease to the MDFA, as part of an integrated care model, you are ensuring patients will be better supported to improve their understanding of their condition, minimise risk factors for progression and live optimally.
Refer a patient
You can refer a patient to Macular Disease Foundation Australia at any stage of their macular disease journey – the earlier the better. We’ll help you support them with free information and non-clinical wellbeing support.
CPD education program
Macular Disease Foundation Australia offers free high-quality CPD, accredited by Optometry Australia, featuring leading experts in macular disease.
Order resources
We provide a comprehensive range of information publications and resources to help you support your patients. Resources are available in bulk quantities for health professionals.
MyINTERACT
A unique and free mobile application providing a single place for people to easily view information relevant to their macular disease diagnosis.
Webinars for healthcare professionals
MDFA’s webinars are aimed at improving the outcomes of macular disease.
Research
Macular disease researchers from around the world are searching for treatments and cures. Check the latest updates as well as information on MDFA’s Research Grants Program.
Macula Matters is our free e-newsletter for eye health professionals interested in keeping up-to-date with the latest news and information on macular disease.
Sign up